Prairie View Partners, LLC Moderna, Inc. Transaction History

Prairie View Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$118.5 - $160.53 $20,737 - $28,092	175 New	175 $21,000
Q2 2022 Jul 22, 2022	SELL	$117.13 - $176.59 $35,139 - $52,977	-300 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$129.91 - $234.98 $38,973 - $70,494	300 New	300 $70,000
Q1 2021 Apr 21, 2021	SELL	$109.18 - $185.98 $90,946 - $154,921	-833 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$65.74 - $169.86 $54,761 - $141,493	833 New	833 $87,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Prairie View Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Prairie View Partners, LLC with notifications on news.